DJIA 16,654.77 369.26 2.27%
NASDAQ 4,812.71 115.17 2.45%
S&P 500 1,987.66 47.15 2.43%
market minute promo

Merck & Co., Inc. (NYSE: MRK)



company name or ticker
Company Photos
(Click to zoom)

Does J&J's Submission Of Supplemental New Drug Application For Olysio Warrant A Change In J&J's Valu

Does J&J's Submission Of Supplemental New Drug Application For Olysio Warrant A Change In J&J's Valuation?

Opportunity For Roche To Further Strengthen Its Cancer Business Against Evolving Competition

Did Merck and NewLink Genetics Just Cure Ebola?

Cheer for a potential cure and not for the ensuing profits (or lack thereof).

Charles Brandes Beefs Up Second-Most Valuable Stake in Portfolio

Notable ETF Inflow Detected - IWD, BAC, T, MRK

The 4 Stocks That Held the DJIA Higher on Thursday

Calls Of Note: Wall Street Research Moving The Market On Thursday

Immune Design's Q2 Loss Narrows Y/Y, Focus on Pipeline

An Analysis Of Achillion, A Play On Johnson & Johnson's New Efforts In The Hepatitis C Market

Does J&J’s Submission Of Supplemental New Drug Application For Olysio Warrant A Change In J&J’s Valu

Does J&J’s Submission Of Supplemental New Drug Application For Olysio Warrant A Change In J&J’s Valuation?
See More Articles...